Use of acellular pertussis vaccines in the United States: can we do better?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Review of Vaccines

• Publication date

  2017-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14760584.2017.1393334PMID 29041826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.

  2017cited by this paper
• Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

  2017influential reference
• Investigating the pertussis resurgence in England and Wales, and options for future control

  2016cited by this paper
• Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

  2016influential reference
• The pertussis enigma: reconciling epidemiology, immunology and evolution

  2016cited by this paper
• Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

  2016cited by this paper
• Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.

  2016cited by this paper
• The Pertussis Problem and a Possible Solution: Will Parents Go Along?

  2016cited by this paper
• Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine.

  2016cited by this paper
• Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States.

  2016cited by this paper
• Modeling the Effects of Priming With the Whole-Cell Bordetella Pertussis Vaccine.

  2016cited by this paper
• Effectiveness of pertussis vaccination and duration of immunity

  2016cited by this paper
• Waning Tdap Effectiveness in Adolescents

  2016cited by this paper
• Pertussis: Microbiology, Disease, Treatment, and Prevention

  2016cited by this paper
• Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.

  2016cited by this paper
• What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

  2015cited by this paper
• National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014

  2015cited by this paper
• Duration of Pertussis Immunity After DTaP Immunization: A Meta-analysis

  2015cited by this paper
• Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.

  2015cited by this paper
• Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic

  2015cited by this paper
• Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.

  2014cited by this paper
• Licensed pertussis vaccines in the United States

  2014influential reference
• Effectiveness of pertussis vaccines for adolescents and adults: case-control study

  2013cited by this paper
• Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

  2013cited by this paper
• Priming with whole-cell versus acellular pertussis vaccine.

  2013cited by this paper
• Strategies to control pertussis in infants

  2013cited by this paper
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012

  2013cited by this paper
• Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

  2013cited by this paper
• Waning Immunity to Pertussis Following 5 Doses of DTaP

  2013cited by this paper
• Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

  2012cited by this paper
• Waning protection after fifth dose of acellular pertussis vaccine in children.

  2012cited by this paper
• Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease.

  2012cited by this paper
• Number and order of whole cell pertussis vaccines in infancy and disease protection.

  2012cited by this paper
• Is adolescent pertussis vaccination preferable to natural booster infections?

  2011cited by this paper
• Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

  2010cited by this paper
• Salmonella newport infections associated with consumption of unpasteurized milk - Utah, April-June 2010.

  2010cited by this paper
• PERTUSSIS VACCINE EFFECTIVENESS AFTER MASS IMMUNIZATION OF HIGH SCHOOL STUDENTS IN AUSTRALIA

  2009cited by this paper
• Modulation of the infant immune responses by the first pertussis vaccine administrations.

  2007cited by this paper
• Duration of Immunity Against Pertussis After Natural Infection or Vaccination

  2005cited by this paper
• Efficacy of an acellular pertussis vaccine among adolescents and adults.

  2005cited by this paper
• Shifts of Bordetella pertussis Variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs

  2005cited by this paper
• Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children

  1998cited by this paper
• Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  1997cited by this paper

• Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness

  2021cites this paper
• Pertussis vaccine is only modestly effective in adults: Another piece in the pertussis puzzle.

  2020cites this paper
• Pertussis

  2020cites this paper
• [Epidemiology of pertussis and prevention strategies: problems and perspectives].

  2019cites this paper
• Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.

  2019cites this paper
• Future strategic plan for national immunisation program in Iran: cost effectiveness of acellular pertussis versus whole-cell

  2018cites this paper
• Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

  2018cites this paper
• Rethinking the efficacy of acellular pertussis vaccines for primary immunization

  2018cites this paper
• Adolescents trust physicians for vaccine information more than their parents or religious leaders

  2018cites this paper